Research Coordinator: Elizabeth Tkachenko Online Study Conducted by: University of Massachusetts Medical School Department of Dermatology The goal of this study is to observe how vitiligo changes, moves, or resolves over time using self-taken, “selfie” photographs. If you choose to participate, you will send us one photo per week for 52 weeks (one year). By […]
Researchers from Istanbul, Turkey noted that nail abnormalities (NAb) have been documented in various other autoimmune diseases associated with vitiligo, and suggested that the same should be apparent in vitiligo patients. With prior research on the topic being limited to a single report, they conducted a two-year study to determine the frequency and type of […]
Dr. Richard Spritz of the University of Colorado at Denver and his team from around the world have been researching the genetics of vitiligo for many years. His previous genome-wide association studies (GWAS 1 & GWAS 2) found 27 genetic loci (where a gene sits on one or more of the 23 chromosomes that make […]
Disclaimer: This information is intended only for informational purposes. Only a physician can determine the best treatment for you. VSI regularly hears from patients from all over the United States who have been denied insurance coverage for their vitiligo treatment. VSI has been fighting this battle on a national level for several years. While we […]
Open-label Pilot Study of Abatacept for the Treatment of Vitiligo Principal Investigator: Dr. Victor Huang Study Location: Brigham and Women’s Hospital Clinical Research Program 221 Longwood Ave. Boston, MA 02115 Abatacept has been shown to decrease T cell activity and reduce symptoms associated with rheumatoid arthritis. Similar pathways have been shown to be involved in […]
Abatacept has been shown to decrease T cell activity and reduce symptoms associated with rheumatoid arthritis. Similar pathways have been shown to be involved in vitiligo.